Estimated delivery in United States, on Wednesday 5 Jun 2024
Product Information
Name:
Tofacitinib Citrate
Controlled Product
Synonyms:
- (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-ß-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate (1:1)
- 3-Piperidinamine
- 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-
- (3R,4R)-
- 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (9CI)
- CP 690500-10
- CP 690550-10
- Tasocitinib citrate
- Xeljanz
- (3R,4R)-1-(Cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-3-piperidinamine 2-hydroxy-1,2,3-propanetricarboxylate
- See more synonyms
- (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile 2-Hydroxy-1,2,3-propanetricarboxylate
- 1-Piperidinepropanenitrile, 4-Methyl-3-(Methyl-7H-Pyrrolo[2,3-D]Pyrimidin-4-Ylamino)-Beta-Oxo-, (3R,4R)-, 2-Hydroxy-1,2,3-Propanetricarboxylate (1:1)
- 3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo[2,3-d]pyrimidin-4-yl-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- Cp 690500-10
- Cp 690550-10
- Tofacitinib citrate
- Tofacitnib Citrate
- Xeljanz XR
CAS:
Brand:
Mikromol
Long term storage:
Notes:
Chemical properties
Molecular weight:
504.49
Formula:
C16H20N6O·C6H8O7
Color/Form:
Neat
InChI:
/m1./s1, InChI=1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16, 7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20), 13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+
SMILES:
C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12.O=C(O)CC(O)(CC(=O)O)C(=O)O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 86-MM3734.00-0250 Tofacitinib Citrate
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
